Ticagrelor is a potent P2Y12 receptor antagonist used for acute coronary syndrome (ACS) and secondary prevention of cardiovascular events. Unlike other antiplatelet agents, Ticagrelor offers reversible binding and a faster onset of action. Its use significantly reduces the risk of myocardial infarction, stroke, and cardiovascular death. Ticagrelor is a widely trusted therapy in interventional cardiology.

Explore Royal Pharma as your potential partner for Ticagrelor API.